Filling the need for trusted information on national health issues…

Trending on kff Ebola Marketplaces Enrollment

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
J&J Announces Collaboration With Stop TB Partnership To Improve Access To TB Drug

Media sources report on efforts by Johnson & Johnson to improve access to Sirturo, its medication for drug-resistant tuberculosis (TB). Bloomberg News: J&J Eases Access for Tuberculosis Drug in Poor Nations “Johnson & Johnson is taking steps to ensure Sirturo, its medicine for people with drug-resistant tuberculosis, is available and…

Growing Humanitarian Needs Raise Private Sector Aid Involvement, Report Says

IRIN: Global crises raise private aid profile “Rising global humanitarian needs — from the Syrian crisis to the conflicts in the Central African Republic and South Sudan — have provided challenges for aid funding and highlight the growing significance of private donations in terms of diversity and flexibility in relief…

GSK Executive Discusses Vaccine R&D Investments, Challenges

Bloomberg TV: Upfront Vaccine Costs a Hurdle to Business: Slaoui In a video report, “Moncef Slaoui, R&D and vaccines chairman at GlaxoSmithKline, discusses the financial challenges to developing vaccines, the importance of research and development to the pharmaceutical industry from the 2014 Milken Global Conference on Bloomberg Television’s ‘Market Makers'”…

‘Power Of Partnership’ Essential To Effective Vaccine Delivery

Raja Rao, senior program officer on the Vaccine Delivery team at the Bill & Melinda Gates Foundation, writes in the foundation’s “Impatient Optimists” blog, “Before my career in vaccine delivery, I considered the fridge nothing more than a place where lettuce goes to die. But it’s a critical component in…

Individuals, Private Sector Should Donate More To Reduce Child Mortality

Huffington Post: The World’s 10 Deadliest Countries for Children and What You Can Do About It Nick Pearson, founder of 1% for Humanity Listing the top 10 countries with the highest child mortality levels as a percentage of their population, Pearson writes, “It can confidently be estimated that only a…

Sanaria Looks To Use Robot For Malaria Research

New York Times: A Goal to Combat Malaria With the Help of a Robot “In its effort to develop a unique malaria vaccine, the American company Sanaria wants to build a robot that will do what now requires a line of trained humans with microscopes: dissecting half-frozen mosquitoes with tiny…

Program Uses Private-Sector Approaches To Address Maternal Mortality

Writing in the Harvard Business Review blog, Michael Rosenblatt, chief medical officer of Merck, discusses Merck for Mothers, an initiative focused on creating “a world where no woman dies from complications during pregnancy and childbirth.” Rosenblatt says, “Maternal mortality is an enormously complicated problem. … But by applying a business…

Minimize Antibiotic Overuse, Develop New Antibiotics To Address Drug Resistance

New York Times: The Rise of Antibiotic Resistance “…The growth of antibiotic-resistant pathogens means that in ever more cases, standard treatments no longer work, infections are harder or impossible to control, the risk of spreading infections to others is increased, and illnesses and hospital stays are prolonged. … The most…

GAVI Alliance Provides Successful Example Of Public-Private Partnership

Natural Resources Defense Council’s “Switchboard”: GAVI: An Encouraging Partnership for Taking Action on Global Goals Chelsea Phipps, a program assistant with the NRDC Action Fund and Global Strategy & Advocacy Program, discusses the GAVI Alliance as “an example of how governments, business, and civil society can work together to produce…

Institute Of Medicine Symposium Addresses Antimicrobial Resistance

Center for Strategic & International Studies’ “Smart Global Health”: (Guarded) Optimism that the world will begin to deal with antimicrobial resistance (AMR) in 2014 J. Christopher Daniel, a senior associate with the CSIS Global Health Policy Center, discusses antimicrobial resistance and a recent Institute of Medicine (IOM) symposium on the…